Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
about
Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouseActivity of Sorafenib against desmoid tumor/deep fibromatosisElevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitroDetermination of stromal signatures in breast carcinoma.Principles in Management of Soft Tissue SarcomaChildren's Oncology Group's 2013 blueprint for research: Soft tissue sarcomasThe GSK-3 family as therapeutic target for myocardial diseasesMesenteric fibromatosis with intestinal involvement mimicking a gastrointestinal stromal tumourImmunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma.Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.Fibro-osseous lesions of the craniofacial bones: β-catenin immunohistochemical analysis and CTNNB1 and APC mutation analysis.Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous woundsClinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.Current trends in the management of extra-abdominal desmoid tumoursSpecific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study.Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).Tissue architecture: the ultimate regulator of epithelial function?Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature.Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction.Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.Inhibition of Wnt/β-catenin pathway promotes regenerative repair of cutaneous and cartilage injury.Role of β-catenin expression in paediatric mesenchymal lesions: a tissue microarray-based immunohistochemical study.Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).Clinical significance of midkine expression in sporadic desmoid tumorsIdentification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumorsThe fibromatosis signature defines a robust stromal response in breast carcinoma.GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanismTargeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.Incidental Finding and Management of Mesenteric Fibromatosis.Desmoplastic fibroblastoma presenting as a parotid tumour: a case report and review of the literature.
P2860
Q21263192-F97AEAE4-DF9C-4156-BC5D-DC9BC754BF65Q24620775-D2391013-A3FF-49C3-9142-A5B9A45B6D1EQ24793854-A6A474AF-57E4-4246-9767-2F4EB5C0AAE8Q24798099-6412BE18-C1CF-4AC0-AAE3-79A1DEFB907BQ26795619-19266A5B-6FA1-47E9-AE5B-E593EC98C12DQ26825000-8F3FE9B0-8332-4C68-864F-AD57F59DBC21Q26861134-DA492543-96D8-4C8C-BB01-79E346CF64A3Q30464438-22800E33-CD39-4750-92AE-B5513CE66FE7Q33271102-239F47B9-629D-4B44-81D8-379B400F3D6AQ33471772-AA52087B-EDCA-458F-93F1-97B42D519061Q33526362-AA67ED9B-577D-4FD5-A09B-5D2AC6B3BDC0Q33747348-4F3A996C-C6A3-4F8C-A58C-A100D4D73EFCQ33894889-D065269D-5CDB-4EF8-864C-252E3A272DF2Q34021254-F06E2C37-3FBD-401C-A92D-EAD4B7CFEF29Q34039279-F55D0D34-ECB2-40E3-803C-389F608B2C95Q34068062-69B0AFE2-9F4A-4359-A8E1-6473D7A860C5Q34077555-2A80D360-76F8-44B5-80E0-308F2D1E75F7Q34292713-8EB2C6BB-F3FB-4737-8EA7-57DC8A3AAE9DQ34590630-EE031471-B4E2-4ED3-8882-FD8150E6736FQ34597947-EE5021BC-5DF0-48C0-B61F-FBB9502E55E6Q34670333-47D7731B-9C53-4E69-ADEA-A3060A851D8EQ35006864-AE0FE7D5-58AE-41ED-941E-02AD84D70F8CQ35212052-19F6E9AC-BBFC-4082-B410-764F89B6BEADQ35749152-CE3F834B-78DF-4FF6-9CB1-B4A2069CA52DQ35787682-EC2C9D7B-4D2A-4B6E-BE2E-6D6C4DA7C7E9Q35803854-616B38E4-0258-4FC7-8B9F-C9DFB14F9A76Q35994704-169DBED7-7844-4760-B461-BD6ECD34989FQ36114566-A28290F3-824B-4B0C-A8C8-CE2123BC21CEQ36189271-262C2AB4-BDFB-4A05-8C65-E7E87F856011Q36283018-74E20DF8-B7FA-434A-A0EF-DAF6737A2824Q36299831-4CD4D818-C339-4874-8F6E-972494711AC2Q36386037-759A8BD7-A24A-40D5-B400-FAE0B35A2C83Q36623084-D37230CC-002F-4457-9AEB-C3F8D577A047Q36640207-599772D3-85EE-48A4-A8FF-4FFA312C4E1CQ36699353-1CD17140-7E7A-47A9-ADCB-7873CD1EEADAQ36841980-202D05E5-A7B0-404F-BFE7-ACF18088D643Q36890830-18B953BD-FD57-41F0-9D37-9055850230C3Q36945923-CBD886A9-23B2-47D2-BFFB-7F98A24A7D31Q37028930-BAA80DE0-CC04-4AFE-A489-E035D1595E39Q37083218-6C6B1920-87F4-4FE9-9E61-5AF462A74200
P2860
Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Increased beta-catenin protein ...... fibromatoses (desmoid tumors).
@en
Increased beta-catenin protein ...... oradic aggressive fibromatoses
@nl
type
label
Increased beta-catenin protein ...... fibromatoses (desmoid tumors).
@en
Increased beta-catenin protein ...... oradic aggressive fibromatoses
@nl
prefLabel
Increased beta-catenin protein ...... fibromatoses (desmoid tumors).
@en
Increased beta-catenin protein ...... oradic aggressive fibromatoses
@nl
P2093
P2860
P1476
Increased beta-catenin protein ...... fibromatoses (desmoid tumors).
@en
P2093
P2860
P304
P407
P577
1997-08-01T00:00:00Z